Here, we showed that MADM-ML could be used in combination with Math1-Cre to produce fully penetrant medulloblastoma in a consistent timeframe, thereby making this model highly suitable for both basic research on tumor progression and pre-clinical evaluation of drug candidates. Here, ATOH1 is linked to medulloblastoma.